2020 Q4 Form 10-Q Financial Statement

#000079929220000114 Filed on October 30, 2020

View on sec.gov

Income Statement

Concept 2020 Q4 2020 Q3 2019 Q3
Revenue $906.4M $847.9M $653.3M
YoY Change 22.13% 29.78% 15.06%
Cost Of Revenue $689.2M $653.4M $519.2M
YoY Change 15.95% 25.86% 14.85%
Gross Profit $217.2M $194.5M $134.2M
YoY Change 52.13% 44.96% 15.86%
Gross Profit Margin 23.96% 22.94% 20.54%
Selling, General & Admin $105.8M $98.42M $79.53M
YoY Change 21.75% 23.75% 10.54%
% of Gross Profit 48.71% 50.6% 59.27%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.900M $3.900M $3.400M
YoY Change 14.71% 14.71% 13.33%
% of Gross Profit 1.8% 2.0% 2.53%
Operating Expenses $105.9M $98.42M $79.53M
YoY Change 21.86% 23.75% 10.54%
Operating Profit $111.3M $96.10M $54.65M
YoY Change 99.19% 75.84% 24.59%
Interest Expense -$1.100M $1.239M $4.637M
YoY Change -76.09% -73.28% 4.77%
% of Operating Profit -0.99% 1.29% 8.49%
Other Income/Expense, Net
YoY Change
Pretax Income $101.9M $95.11M $50.06M
YoY Change 98.64% 89.97% 26.81%
Income Tax $21.80M $21.60M $12.23M
% Of Pretax Income 21.39% 22.71% 24.42%
Net Earnings $80.10M $73.54M $37.84M
YoY Change 91.63% 94.35% 29.22%
Net Earnings / Revenue 8.84% 8.67% 5.79%
Basic Earnings Per Share $2.57 $1.35
Diluted Earnings Per Share $2.715M $2.51 $1.32
COMMON SHARES
Basic Shares Outstanding 28.75M shares 28.65M shares 27.98M shares
Diluted Shares Outstanding 29.29M shares 28.60M shares

Balance Sheet

Concept 2020 Q4 2020 Q3 2019 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $260.8M $202.5M $33.50M
YoY Change 4175.41% 504.48% -7.97%
Cash & Equivalents $260.8M $202.5M $33.45M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory $1.917B $1.843B $1.827B
Prepaid Expenses
Receivables $234.3M $140.0M $128.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $2.412B $2.186B $1.989B
YoY Change 24.91% 9.9% 4.51%
LONG-TERM ASSETS
Property, Plant & Equipment $26.61M $25.70M $27.62M
YoY Change 20.32% -6.97% -3.73%
Goodwill $16.40M $16.40M $16.40M
YoY Change 0.0% 0.0% 0.0%
Intangibles
YoY Change
Long-Term Investments $34.67M $34.04M $47.56M
YoY Change -8.48% -28.43% 93.57%
Other Assets $6.200M $9.200M $12.00M
YoY Change -35.42% -23.33% -28.99%
Total Long-Term Assets $231.3M $234.7M $192.7M
YoY Change 32.35% 21.77% 24.14%
TOTAL ASSETS
Total Short-Term Assets $2.412B $2.186B $1.989B
Total Long-Term Assets $231.3M $234.7M $192.7M
Total Assets $2.643B $2.421B $2.182B
YoY Change 25.52% 10.95% 5.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $185.7M $176.6M $169.5M
YoY Change 48.56% 4.19% 14.22%
Accrued Expenses $52.50M $52.70M $19.10M
YoY Change 185.33% 175.92%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $310.8M $295.9M $224.9M
YoY Change 74.7% 31.57% 19.12%
LONG-TERM LIABILITIES
Long-Term Debt $871.9M $783.3M $849.7M
YoY Change 15.51% -7.81% -3.4%
Other Long-Term Liabilities $201.7M $166.6M $152.4M
YoY Change 19.07% 9.32% -1.42%
Total Long-Term Liabilities $1.074B $949.9M $1.002B
YoY Change 16.17% -5.21% -3.1%
TOTAL LIABILITIES
Total Short-Term Liabilities $310.8M $295.9M $224.9M
Total Long-Term Liabilities $1.074B $949.9M $1.002B
Total Liabilities $1.384B $1.246B $1.227B
YoY Change 25.61% 1.54% 0.31%
SHAREHOLDERS EQUITY
Retained Earnings $948.5M $868.4M $666.8M
YoY Change 33.85% 30.23% 21.55%
Common Stock $339.3M $336.9M $331.4M
YoY Change 1.84% 1.66% 0.8%
Preferred Stock
YoY Change
Treasury Stock (at cost) $29.06M $30.55M $43.59M
YoY Change -24.06% -29.9% 3.3%
Treasury Stock Shares 1.323M shares 1.391M shares 1.994M shares
Shareholders Equity $1.259B $1.175B $954.6M
YoY Change
Total Liabilities & Shareholders Equity $2.643B $2.421B $2.182B
YoY Change 25.52% 10.95% 5.99%

Cashflow Statement

Concept 2020 Q4 2020 Q3 2019 Q3
OPERATING ACTIVITIES
Net Income $80.10M $73.54M $37.84M
YoY Change 91.63% 94.35% 29.22%
Depreciation, Depletion And Amortization $3.900M $3.900M $3.400M
YoY Change 14.71% 14.71% 13.33%
Cash From Operating Activities -$28.90M $114.4M -$9.600M
YoY Change -144.74% -1291.67% -82.29%
INVESTING ACTIVITIES
Capital Expenditures -$3.200M -$6.500M -$1.000M
YoY Change 68.42% 550.0% -23.08%
Acquisitions
YoY Change
Other Investing Activities $700.0K -$4.200M -$8.000M
YoY Change -47.5% -50.62%
Cash From Investing Activities -$2.600M -$10.60M -$9.000M
YoY Change 36.84% 17.78% -48.28%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 89.80M 4.700M 31.70M
YoY Change -199.56% -85.17% -21.14%
NET CHANGE
Cash From Operating Activities -28.90M 114.4M -9.600M
Cash From Investing Activities -2.600M -10.60M -9.000M
Cash From Financing Activities 89.80M 4.700M 31.70M
Net Change In Cash 58.30M 108.5M 13.10M
YoY Change -312.0% 728.24% -141.72%
FREE CASH FLOW
Cash From Operating Activities -$28.90M $114.4M -$9.600M
Capital Expenditures -$3.200M -$6.500M -$1.000M
Free Cash Flow -$25.70M $120.9M -$8.600M
YoY Change -138.65% -1505.81% -83.74%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
dei Entity Central Index Key
EntityCentralIndexKey
0000799292
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
58000000 shares
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
58000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30137141 shares
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30137141 shares
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1391492 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1750685 shares
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
252000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
52000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
307000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
118000 USD
CY2019Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
CY2019Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
CY2019 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
0 USD
CY2020Q3 mho Loan Repurchase Guarantee Liability
LoanRepurchaseGuaranteeLiability
500000 USD
CY2019Q4 mho Loan Repurchase Guarantee Liability
LoanRepurchaseGuaranteeLiability
500000 USD
CY2020Q3 mho Total Of Guaranteed Loans Inquired About
TotalOfGuaranteedLoansInquiredAbout
600000 USD
CY2019Q4 mho Total Of Guaranteed Loans Inquired About
TotalOfGuaranteedLoansInquiredAbout
600000 USD
CY2020Q3 mho Maximum Borrowing Availability Under All Credit Lines
MaximumBorrowingAvailabilityUnderAllCreditLines
225000000.0 USD
CY2019Q4 mho Maximum Borrowing Availability Under All Credit Lines
MaximumBorrowingAvailabilityUnderAllCreditLines
225000000.0 USD
CY2020Q3 mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.97 Rate
CY2019Q3 mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.98 Rate
mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.97 Rate
mho Homebuildingoperationspercentoftotalrevenue
Homebuildingoperationspercentoftotalrevenue
0.98 Rate
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2020-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
1-12434
dei Entity Registrant Name
EntityRegistrantName
M/I HOMES, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
OH
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
31-1210837
dei Entity Address Address Line1
EntityAddressAddressLine1
4131 Worth Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 500
dei Entity Address City Or Town
EntityAddressCityOrTown
Columbus
dei Entity Address State Or Province
EntityAddressStateOrProvince
OH
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
43219
dei City Area Code
CityAreaCode
614
dei Local Phone Number
LocalPhoneNumber
418-8000
dei Security12b Title
Security12bTitle
Common Shares, par value $.01
dei Trading Symbol
TradingSymbol
MHO
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2020Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
28745649 shares
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202512000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6083000 USD
CY2020Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
140046000 USD
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
155244000 USD
CY2020Q3 us-gaap Inventory Real Estate
InventoryRealEstate
1843409000 USD
CY2019Q4 us-gaap Inventory Real Estate
InventoryRealEstate
1769507000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25696000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22118000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
34038000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52574000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18415000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9205000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
37885000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9631000 USD
CY2020Q3 us-gaap Goodwill
Goodwill
16400000 USD
CY2019Q4 us-gaap Goodwill
Goodwill
16400000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
96675000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
70311000 USD
CY2020Q3 us-gaap Assets
Assets
2420555000 USD
CY2019Q4 us-gaap Assets
Assets
2105594000 USD
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
176581000 USD
CY2019Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
125026000 USD
CY2020Q3 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
66632000 USD
CY2019Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
34462000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
52666000 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18415000 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
156390000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
147937000 USD
CY2020Q3 us-gaap Special Assessment Bond Noncurrent
SpecialAssessmentBondNoncurrent
9892000 USD
CY2019Q4 us-gaap Special Assessment Bond Noncurrent
SpecialAssessmentBondNoncurrent
13531000 USD
CY2020Q3 mho Obligation For Consolidated Inventory Not Owned
ObligationForConsolidatedInventoryNotOwned
364000 USD
CY2019Q4 mho Obligation For Consolidated Inventory Not Owned
ObligationForConsolidatedInventoryNotOwned
7934000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
66000000 USD
CY2020Q3 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
136119000 USD
CY2019Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
136904000 USD
CY2020Q3 us-gaap Other Notes Payable
OtherNotesPayable
5325000 USD
CY2019Q4 us-gaap Other Notes Payable
OtherNotesPayable
5828000 USD
CY2020Q3 mho Seniornotesdue2021
Seniornotesdue2021
0 USD
CY2019Q4 mho Seniornotesdue2021
Seniornotesdue2021
298988000 USD
CY2020Q3 mho Seniornotesdue2025
Seniornotesdue2025
247483000 USD
CY2019Q4 mho Seniornotesdue2025
Seniornotesdue2025
247092000 USD
CY2020Q3 mho Seniornotesdue2028
Seniornotesdue2028
394363000 USD
CY2019Q4 mho Seniornotesdue2028
Seniornotesdue2028
0 USD
CY2020Q3 us-gaap Liabilities
Liabilities
1245815000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1102117000 USD
CY2020Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2020Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
58000000 shares
CY2020Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
30137141 shares
CY2020Q3 us-gaap Common Stock Value
CommonStockValue
301000 USD
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
301000 USD
CY2020Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
336623000 USD
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
332861000 USD
CY2020Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
868370000 USD
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
708579000 USD
CY2020Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
1391492 shares
CY2019Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
1750685 shares
CY2020Q3 us-gaap Treasury Stock Value
TreasuryStockValue
30554000 USD
CY2019Q4 us-gaap Treasury Stock Value
TreasuryStockValue
38264000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1174740000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1003477000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2420555000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2105594000 USD
CY2020Q3 us-gaap Revenues
Revenues
847921000 USD
CY2019Q3 us-gaap Revenues
Revenues
653345000 USD
us-gaap Revenues
Revenues
2139718000 USD
us-gaap Revenues
Revenues
1758140000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
653407000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
519164000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1672122000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1411488000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48879000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39385000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
123763000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106248000 USD
CY2020Q3 us-gaap Selling Expense
SellingExpense
49539000 USD
CY2019Q3 us-gaap Selling Expense
SellingExpense
40147000 USD
us-gaap Selling Expense
SellingExpense
127494000 USD
us-gaap Selling Expense
SellingExpense
109150000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
252000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
52000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
307000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
118000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
1239000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
4637000 USD
us-gaap Interest Expense
InterestExpense
8454000 USD
us-gaap Interest Expense
InterestExpense
16626000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
752812000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
603281000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1931526000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1643394000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
95109000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
50064000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
208192000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
114746000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21572000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12226000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48401000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28939000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
73537000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37838000 USD
us-gaap Net Income Loss
NetIncomeLoss
159791000 USD
us-gaap Net Income Loss
NetIncomeLoss
85807000 USD
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.57
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.10
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.51
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.04
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28653000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27981000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28554000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27695000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29286000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28598000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29030000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28238000 shares
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1094405000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
73537000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4609000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2189000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1174740000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1003477000 USD
us-gaap Profit Loss
ProfitLoss
159791000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8254000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4915000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1912000 USD
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
215000 USD
us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
0 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1174740000 USD
CY2019Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
904240000 USD
CY2019Q3 us-gaap Profit Loss
ProfitLoss
37838000 USD
CY2019Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
11071000 USD
CY2019Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1492000 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
954641000 USD
CY2018Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
855303000 USD
us-gaap Profit Loss
ProfitLoss
85807000 USD
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
14348000 USD
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
4086000 USD
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
5150000 USD
us-gaap Deferred Compensation Arrangement With Individual Contributions By Employer
DeferredCompensationArrangementWithIndividualContributionsByEmployer
247000 USD
us-gaap Deferred Compensation Arrangement With Individual Distribution Paid
DeferredCompensationArrangementWithIndividualDistributionPaid
0 USD
CY2019Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
954641000 USD
us-gaap Net Income Loss
NetIncomeLoss
159791000 USD
us-gaap Net Income Loss
NetIncomeLoss
85807000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
307000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
118000 USD
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
1287426000 USD
us-gaap Payments For Origination Of Mortgage Loans Held For Sale
PaymentsForOriginationOfMortgageLoansHeldForSale
959022000 USD
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
1301713000 USD
us-gaap Proceeds From Sale Of Mortgage Loans Held For Sale
ProceedsFromSaleOfMortgageLoansHeldForSale
997369000 USD
mho Fair Value Adjustment Of Mortgage Loans Held For Sale
FairValueAdjustmentOfMortgageLoansHeldForSale
-911000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
438000 USD
mho Fair Value Adjustment Of Mortgage Loans Held For Sale
FairValueAdjustmentOfMortgageLoansHeldForSale
-2982000 USD
us-gaap Servicing Asset At Fair Value Period Increase Decrease
ServicingAssetAtFairValuePeriodIncreaseDecrease
507000 USD
us-gaap Servicing Asset At Fair Value Period Increase Decrease
ServicingAssetAtFairValuePeriodIncreaseDecrease
0 USD
us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
4119000 USD
us-gaap Payments For Proceeds From Mortgage Servicing Rights
PaymentsForProceedsFromMortgageServicingRights
3366000 USD
us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
1847000 USD
us-gaap Amortization Of Mortgage Servicing Rights Ms Rs
AmortizationOfMortgageServicingRightsMSRs
1112000 USD
us-gaap Depreciation
Depreciation
9298000 USD
us-gaap Depreciation
Depreciation
8655000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1869000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
2029000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
950000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4915000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
4086000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-426000 USD
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-1494000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
62524000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
156073000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
18493000 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
3952000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
51555000 USD
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
38017000 USD
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
32170000 USD
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
4195000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-4990000 USD
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-11629000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
9133000 USD
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-10609000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
197226000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
977000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8465000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2626000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1213000 USD
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
24075000 USD
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
23522000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31327000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25710000 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
300000000 USD
us-gaap Repayments Of Other Debt
RepaymentsOfOtherDebt
0 USD
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
400000000 USD
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
0 USD
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
306800000 USD
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
568900000 USD
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
372800000 USD
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
496400000 USD
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-785000 USD
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-44574000 USD
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-503000 USD
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-429000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1912000 USD
mho Community Development District Infrastructure
CommunityDevelopmentDistrictInfrastructure
-3639000 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5150000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8524000 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
40000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8254000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14348000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30530000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36655000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
196429000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11922000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6083000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21529000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202512000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33451000 USD
us-gaap Interest Paid Net
InterestPaidNet
15644000 USD
us-gaap Interest Paid Net
InterestPaidNet
23034000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
39510000 USD
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
26578000 USD
mho Community Development District Infrastructure
CommunityDevelopmentDistrictInfrastructure
1936000 USD
mho Consolidated Inventory Not Owned Obligation
ConsolidatedInventoryNotOwnedObligation
-7570000 USD
mho Consolidated Inventory Not Owned Obligation
ConsolidatedInventoryNotOwnedObligation
-12621000 USD
mho Distribution Of Single Family Lots From Unconsolidated Llcs
DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs
27016000 USD
mho Distribution Of Single Family Lots From Unconsolidated Llcs
DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs
11515000 USD
us-gaap Basis Of Accounting
BasisOfAccounting
Basis of Presentation<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying Unaudited Condensed Consolidated Financial Statements (the “financial statements”) of M/I Homes, Inc. and its subsidiaries (the “Company”) and notes thereto have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (the “SEC”) for interim financial information. The financial statements include the accounts of the Company. All intercompany transactions have been eliminated. Results for the interim period are not necessarily indicative of results for a full year, including as a result of the novel coronavirus (COVID-19) pandemic which has disrupted, and is expected to continue to disrupt, our business. In the opinion of management, the accompanying financial statements reflect all adjustments (all of which are normal and recurring in nature) necessary for a fair presentation of financial results for the interim periods presented. These financial statements should be read in conjunction with the Consolidated Financial Statements and Notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2019 (the “2019 Form 10-K”).</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during that period. Actual results could differ from these estimates and have a significant impact on the financial condition and results of operations and cash flows. With regard to the Company, estimates and assumptions are inherent in calculations relating to valuation of inventory and investment in unconsolidated joint ventures, property and equipment depreciation, valuation of derivative financial instruments, accounts payable on inventory, accruals for costs to complete inventory, accruals for warranty claims, accruals for self-insured general liability claims, litigation, accruals for health care and workers’ compensation, accruals for guaranteed or indemnified loans, stock-based compensation expense, income taxes, and contingencies. Items that could have a significant impact on these estimates and assumptions include the risks and uncertainties listed in “Item 1A. Risk Factors” in Part I of our 2019 Form 10-K and in “Item 1A. Risk Factors” in Part II of this Quarterly Report on Form 10-Q, as the same may be updated from time to time in our subsequent filings with the SEC. </span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2016-13”). ASU 2016-13 replaces the current incurred loss impairment methodology with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to estimate credit losses. ASU 2016-13 is effective for our fiscal year beginning January 1, 2020. Subsequent to the issuance of ASU 2016-13, the FASB issued ASU No. 2018-19, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Topic 326, Financial Instruments-Credit Losses</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2018-19”) in November 2018, ASU No. 2019-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Topic 326, Financial Instruments-Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2019-04”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in April 2019, and ASU No. 2019-05, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments-Credit Losses (Topic 326) Targeted Transition Relief </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2019-05”) in May 2019. These ASUs do not change the core principle of the guidance in ASU 2016-13. Instead these amendments are intended to clarify and improve operability of certain topics included within the credit losses standard. These ASUs will have the same effective date and transition requirements as ASU 2016-13. The adoption of ASU 2016-13 on January 1, 2020 did not have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU No. 2018-13, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement (Topic 820): Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2018-13”)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> ASU 2018-13 modifies the disclosure requirements for fair value measurements and removes the requirement to disclose (1) the amount of and reasons for transfers between Level 1 and Level 2 of the fair value hierarchy, (2) the policy for timing of transfers between levels, and (3) the valuation processes for Level 3 fair value measurements. ASU 2018-13 requires disclosure of changes in unrealized gains and losses for the period included in other comprehensive income (loss) for recurring Level 3 fair value measurements held at the end of the reporting period and the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements. For all entities, ASU 2018-13 is effective for fiscal years beginning after December 15, 2019, and interim periods within those fiscal years. Our adoption of ASU 2018-13 on January 1, 2020 did not have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-04, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Facilitation of the Effects of Reference Rate Reform on Financial Reporting </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(“ASU 2020-04”). ASU 2020-04 is intended to provide temporary optional expedients and exceptions to the US </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens related to the expected market transition from the London Interbank Offered Rate (LIBOR) and other interbank offered rates to alternative reference rates. This guidance was effective beginning March 12, 2020 and can be applied prospectively through December 31, 2022. The adoption of this guidance did not have a material impact on our consolidated financial statements and disclosures.</span></div><div style="margin-bottom:10pt;margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Impact of New Accounting Standards and SEC Guidance</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the FASB issued ASU No. 2020-03, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Codification Improvements to Financial Instruments</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2020-03”). ASU 2020-03 improves and clarifies various financial instruments topics, including the current expected credit losses (CECL) standard issued in 2016 (described above). ASU 2020-03 includes seven different issues that describe the areas of improvement and the related amendments to GAAP that are intended to make the standards easier to understand and apply by eliminating inconsistencies and providing clarifications. The amendments have different effective dates. We are currently evaluating the effect of adopting this new accounting guidance, but we do not expect that adoption will have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In May 2020, the SEC adopted Release No.33-10786 “Amendments to Financial Disclosures about Acquired and Disposed Businesses” (the “Final Rule”). The Final Rule is effective on January 1, 2021. However, voluntary early adoption is permitted. We are currently evaluating the effect of adopting this new accounting guidance, but we do not expect that adoption will have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU 2020-06, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt-Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (“ASU 2020-06”), to address the complexity associated with applying GAAP to certain financial instruments with characteristics of liabilities and equity. The ASU includes amendments to the guidance on convertible instruments and the derivative scope exception for contracts in an entity’s own equity and simplifies the accounting for convertible instruments which include beneficial conversion features or cash conversion features by removing certain separation models in Subtopic 470-20. Additionally, the ASU will require entities to use the “if-converted” method when calculating diluted earnings per share for convertible instruments. ASU 2020-06 is effective for fiscal years beginning after December 15, 2021, including interim periods within those fiscal years. We are currently evaluating the effect of adopting this new accounting guidance, but we do not expect that adoption will have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the SEC adopted Release No. 33-10825 “Modernization of Regulation S-K Items 101, 103, and 105” (the “Final S-K Rule”). The Final S-K Rule is effective on November 9, 2020. We are currently evaluating the effect of the Final S-K Rule, but we do not expect it will have a material impact on our consolidated financial statements and disclosures.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div style="text-align:justify"><span><br/></span></div><div style="margin-bottom:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that there have been no significant changes to our significant accounting policies during the quarter ended September 30, 2020 as compared to those disclosed in our 2019 Form 10-K.</span></div>
CY2020Q3 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
840637000 USD
CY2019Q4 us-gaap Inventory Real Estate Land And Land Development Costs
InventoryRealEstateLandAndLandDevelopmentCosts
858065000 USD
CY2020Q3 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
4357000 USD
CY2019Q4 us-gaap Inventory Land Held For Sale
InventoryLandHeldForSale
5670000 USD
CY2020Q3 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
863603000 USD
CY2019Q4 us-gaap Inventory Homes Under Construction
InventoryHomesUnderConstruction
756998000 USD
CY2020Q3 mho Model Home Accumulated Depreciation
ModelHomeAccumulatedDepreciation
14186000 USD
CY2019Q4 mho Model Home Accumulated Depreciation
ModelHomeAccumulatedDepreciation
12723000 USD
CY2020Q3 mho Inventory Model Homes And Furnishings
InventoryModelHomesAndFurnishings
87192000 USD
CY2019Q4 mho Inventory Model Homes And Furnishings
InventoryModelHomesAndFurnishings
98777000 USD
CY2020Q3 mho Community Development District
CommunityDevelopmentDistrict
9892000 USD
CY2019Q4 mho Community Development District
CommunityDevelopmentDistrict
13531000 USD
CY2020Q3 mho Land Purchase Deposits
LandPurchaseDeposits
37364000 USD
CY2019Q4 mho Land Purchase Deposits
LandPurchaseDeposits
28532000 USD
CY2020Q3 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
364000 USD
CY2019Q4 us-gaap Land Under Purchase Options Recorded
LandUnderPurchaseOptionsRecorded
7934000 USD
CY2020Q3 us-gaap Inventory Real Estate
InventoryRealEstate
1843409000 USD
CY2019Q4 us-gaap Inventory Real Estate
InventoryRealEstate
1769507000 USD
CY2020Q3 mho Number Of Speculative Homes
NumberOfSpeculativeHomes
1113 homes
CY2020Q3 mho Speculative Homes Carrying Value
SpeculativeHomesCarryingValue
188400000 USD
CY2019Q4 mho Number Of Speculative Homes
NumberOfSpeculativeHomes
1459
CY2019Q4 mho Speculative Homes Carrying Value
SpeculativeHomesCarryingValue
304000000.0 USD
CY2020Q3 mho Community Development District
CommunityDevelopmentDistrict
9900000 USD
CY2019Q4 mho Community Development District
CommunityDevelopmentDistrict
13500000 USD
CY2020Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
22203000 USD
CY2019Q2 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
22162000 USD
CY2019Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
21607000 USD
CY2018Q4 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
20765000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
8758000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
8291000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
23678000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Incurred
RealEstateInventoryCapitalizedInterestCostsIncurred
22461000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
8803000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
7836000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
23127000 USD
us-gaap Real Estate Inventory Capitalized Interest Costs Cost Of Sales1
RealEstateInventoryCapitalizedInterestCostsCostOfSales1
20609000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
22158000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
22617000 USD
CY2020Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
22158000 USD
CY2019Q3 us-gaap Real Estate Inventory Capitalized Interest Costs
RealEstateInventoryCapitalizedInterestCosts
22617000 USD
CY2020Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
9997000 USD
CY2019Q3 us-gaap Interest Costs Incurred
InterestCostsIncurred
12928000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
32132000 USD
us-gaap Interest Costs Incurred
InterestCostsIncurred
39087000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
34000000.0 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
37900000 USD
mho Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements
Increasedecreaseininvestmentsinunconsolidatedjointventuresandothersimilararrangements
-3900000 USD
mho Distribution Of Single Family Lots From Unconsolidated Llcs
DistributionOfSingleFamilyLotsFromUnconsolidatedLlcs
27000000.0 USD
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
24100000 USD
CY2020Q3 mho Companysinvestmentinjointdevelopmentorsimilaragreements
Companysinvestmentinjointdevelopmentorsimilaragreements
32100000 USD
CY2019Q4 mho Companysinvestmentinjointdevelopmentorsimilaragreements
Companysinvestmentinjointdevelopmentorsimilaragreements
35500000 USD
CY2020Q3 mho Equityinvestedin Ll Cs
EquityinvestedinLLCs
1900000 USD
CY2019Q4 mho Equityinvestedin Ll Cs
EquityinvestedinLLCs
2400000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
300000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
100000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
34000000.0 USD
us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
400000 USD
CY2020Q3 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
100000 USD
us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
500000 USD
us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
500000 USD
CY2020Q3 mho Notional Amount Of Best Effort Contracts And Related Committed Interest Rate Lock Commitments
NotionalAmountOfBestEffortContractsAndRelatedCommittedInterestRateLockCommitments
2924000 USD
CY2019Q4 mho Notional Amount Of Best Effort Contracts And Related Committed Interest Rate Lock Commitments
NotionalAmountOfBestEffortContractsAndRelatedCommittedInterestRateLockCommitments
1445000 USD
CY2020Q3 mho Notional Amount Of Uncommitted Interest Rate Lock Commitments
NotionalAmountOfUncommittedInterestRateLockCommitments
213146000 USD
CY2019Q4 mho Notional Amount Of Uncommitted Interest Rate Lock Commitments
NotionalAmountOfUncommittedInterestRateLockCommitments
87340000 USD
CY2020Q3 mho Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments
ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments
186000000 USD
CY2019Q4 mho Forward Sales Of Mortgage Backed Securities Related To Uncommitted Interest Rate Lock Commitments
ForwardSalesOfMortgageBackedSecuritiesRelatedToUncommittedInterestRateLockCommitments
88000000 USD
CY2020Q3 mho Best Effort Contracts And Related Mortgage Loans Held For Sale
BestEffortContractsAndRelatedMortgageLoansHeldForSale
13750000 USD
CY2019Q4 mho Best Effort Contracts And Related Mortgage Loans Held For Sale
BestEffortContractsAndRelatedMortgageLoansHeldForSale
6125000 USD
CY2020Q3 mho Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale
ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale
116000000 USD
CY2019Q4 mho Forward Sales Of Mortgage Backed Securities Related To Mortgage Loans Held For Sale
ForwardSalesOfMortgageBackedSecuritiesRelatedToMortgageLoansHeldForSale
144000000 USD
CY2020Q3 mho Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities
MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities
120257000 USD
CY2019Q4 mho Mortgage Loans Held For Sale Covered By Forward Sales Of Mortgage Backed Securities
MortgageLoansHeldForSaleCoveredByForwardSalesOfMortgageBackedSecurities
144411000 USD
CY2020Q3 mho Gain Loss On Assets And Liabilities Measured On Recurring Basis
GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis
-541000 USD
CY2019Q3 mho Gain Loss On Assets And Liabilities Measured On Recurring Basis
GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis
-230000 USD
mho Gain Loss On Assets And Liabilities Measured On Recurring Basis
GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis
232000 USD
mho Gain Loss On Assets And Liabilities Measured On Recurring Basis
GainLossOnAssetsAndLiabilitiesMeasuredOnRecurringBasis
566000 USD
CY2020Q3 us-gaap Asset Impairment Charges
AssetImpairmentCharges
0 USD
CY2020Q3 us-gaap Equity Method Investment Other Than Temporary Impairment
EquityMethodInvestmentOtherThanTemporaryImpairment
0 USD
CY2020Q3 mho Total Of Loans Covered By Guarantees
TotalOfLoansCoveredByGuarantees
5700000 USD
CY2019Q4 mho Total Of Loans Covered By Guarantees
TotalOfLoansCoveredByGuarantees
48100000 USD
CY2020Q3 mho Total Of Guaranteed Loans Inquired About
TotalOfGuaranteedLoansInquiredAbout
600000 USD
CY2020Q3 mho Total Loans Indemnified
TotalLoansIndemnified
600000 USD
CY2019Q4 mho Total Loans Indemnified
TotalLoansIndemnified
1000000.0 USD
CY2020Q3 mho Loan Repurchase Guarantee Liability
LoanRepurchaseGuaranteeLiability
500000 USD
CY2020Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
26175000 USD
CY2019Q2 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25474000 USD
CY2019Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
26420000 USD
CY2018Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
26459000 USD
CY2020Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
4961000 USD
CY2019Q3 us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
3851000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
12624000 USD
us-gaap Product Warranty Accrual Warranties Issued
ProductWarrantyAccrualWarrantiesIssued
10332000 USD
CY2020Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
416000 USD
CY2019Q3 us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
255000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
-228000 USD
us-gaap Product Warranty Accrual Preexisting Increase Decrease
ProductWarrantyAccrualPreexistingIncreaseDecrease
990000 USD
CY2020Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
0 USD
CY2019Q3 us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
0 USD
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
0 USD
us-gaap Product Warranty Accrual Period Increase Decrease
ProductWarrantyAccrualPeriodIncreaseDecrease
0 USD
CY2020Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4578000 USD
CY2019Q3 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
4044000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
11842000 USD
us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
12245000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
26974000 USD
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25536000 USD
CY2020Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
26974000 USD
CY2019Q3 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25536000 USD
mho Stucco Repair Cost
StuccoRepairCost
500000 USD
us-gaap Insurance Recoveries
InsuranceRecoveries
500000 USD
CY2020Q3 mho Estimated Repair Costsfor Affected Homes
EstimatedRepairCostsforAffectedHomes
3700000 USD
CY2020Q3 mho Letters Of Credit And Bonds
LettersOfCreditAndBonds
267700000 USD
CY2020Q3 mho Outstanding Performance Bonds
OutstandingPerformanceBonds
194100000 USD
CY2020Q3 mho Performance Letters Of Credit Outstanding
PerformanceLettersOfCreditOutstanding
55100000 USD
CY2020Q3 mho Financial Letters Of Credit
FinancialLettersOfCredit
11500000 USD
CY2020Q3 mho Outstanding Letters Of Credit In Lieu Of Cash Deposits Under Certain Land Option Contracts
OutstandingLettersOfCreditInLieuOfCashDepositsUnderCertainLandOptionContracts
11000000.0 USD
CY2020Q3 mho Financial Bonds
FinancialBonds
7000000.0 USD
CY2020Q3 us-gaap Purchase Options Land
PurchaseOptionsLand
801400000 USD
CY2020Q3 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
900000 USD
CY2019Q4 us-gaap Loss Contingency Accrual At Carrying Value
LossContingencyAccrualAtCarryingValue
700000 USD
CY2020Q3 us-gaap Debt Instrument Unused Borrowing Capacity Amount
DebtInstrumentUnusedBorrowingCapacityAmount
829600000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q3 mho Letters Of Credit Outstanding Under Credit Facility
LettersOfCreditOutstandingUnderCreditFacility
66600000 USD
CY2020Q3 us-gaap Line Of Credit Facility Remaining Borrowing Capacity
LineOfCreditFacilityRemainingBorrowingCapacity
433400000 USD
CY2020Q3 mho Maximum Borrowing Availability Under All Credit Lines
MaximumBorrowingAvailabilityUnderAllCreditLines
225000000.0 USD
CY2020Q3 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
136100000 USD
CY2019Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
136900000 USD
CY2020Q3 us-gaap Equity Restrictions
EquityRestrictions
328600000 USD
CY2019Q4 us-gaap Equity Restrictions
EquityRestrictions
264500000 USD
CY2020Q3 us-gaap Other Notes Payable
OtherNotesPayable
5300000 USD
CY2019Q4 us-gaap Other Notes Payable
OtherNotesPayable
5800000 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
73537000 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37838000 USD
us-gaap Net Income Loss
NetIncomeLoss
159791000 USD
us-gaap Net Income Loss
NetIncomeLoss
85807000 USD
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28653000 shares
CY2019Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27981000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28554000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
27695000 shares
CY2020Q3 mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
376000 shares
CY2019Q3 mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
403000 shares
mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
253000 shares
mho Incremental Common Shares Attributable To Stock Options
IncrementalCommonSharesAttributableToStockOptions
338000 shares
CY2020Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
257000 shares
CY2019Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
214000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
223000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
205000 shares
CY2020Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29286000 shares
CY2019Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28598000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29030000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28238000 shares
CY2020Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.57
CY2019Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.35
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
5.60
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
3.10
CY2020Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.51
CY2019Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.32
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
5.50
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.04
CY2020Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
435000 shares
CY2019Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
360000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
412000 shares
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21600000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12200000 USD
CY2020Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.227 Rate
CY2019Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.244 Rate
CY2020Q3 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
2500000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48400000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28900000 USD
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.232 Rate
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.252 Rate
us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
3700000 USD
us-gaap Proceeds And Excess Tax Benefit From Sharebased Compensation
ProceedsAndExcessTaxBenefitFromSharebasedCompensation
400000 USD
CY2020Q3 us-gaap Revenues
Revenues
847921000 USD
CY2019Q3 us-gaap Revenues
Revenues
653345000 USD
us-gaap Revenues
Revenues
2139718000 USD
us-gaap Revenues
Revenues
1758140000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
96096000 USD
CY2019Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
54649000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
216339000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
131254000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
1239000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
4637000 USD
us-gaap Interest Expense
InterestExpense
8454000 USD
us-gaap Interest Expense
InterestExpense
16626000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
252000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
52000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
307000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
118000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
95109000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
50064000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
208192000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
114746000 USD
CY2020Q3 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
37364000 USD
CY2020Q3 mho Inventory Segments
InventorySegments
1806045000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
34038000 USD
CY2020Q3 mho Other Combined Assets
OtherCombinedAssets
543108000 USD
CY2020Q3 us-gaap Assets
Assets
2420555000 USD
CY2019Q4 us-gaap Advances On Inventory Purchases
AdvancesOnInventoryPurchases
28532000 USD
CY2019Q4 mho Inventory Segments
InventorySegments
1740975000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
37885000 USD
CY2019Q4 mho Other Combined Assets
OtherCombinedAssets
298202000 USD
CY2019Q4 us-gaap Assets
Assets
2105594000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
34200000 USD
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
34200000 USD
CY2020Q3 us-gaap Revenues
Revenues
847921000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
653407000 USD
CY2020Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
48879000 USD
CY2020Q3 us-gaap Selling Expense
SellingExpense
49539000 USD
CY2020Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
252000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
1239000 USD
CY2020Q3 us-gaap Costs And Expenses
CostsAndExpenses
752812000 USD
CY2020Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
95109000 USD
CY2020Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21572000 USD
CY2020Q3 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
CY2020Q3 us-gaap Net Income Loss
NetIncomeLoss
73537000 USD
CY2019Q3 us-gaap Revenues
Revenues
653345000 USD
CY2019Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
519164000 USD
CY2019Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
39385000 USD
CY2019Q3 us-gaap Selling Expense
SellingExpense
40147000 USD
CY2019Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
52000 USD
CY2019Q3 us-gaap Interest Expense
InterestExpense
4637000 USD
CY2019Q3 us-gaap Costs And Expenses
CostsAndExpenses
603281000 USD
CY2019Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
50064000 USD
CY2019Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
12226000 USD
CY2019Q3 us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
CY2019Q3 us-gaap Net Income Loss
NetIncomeLoss
37838000 USD
us-gaap Revenues
Revenues
2139718000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1672122000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
123763000 USD
us-gaap Selling Expense
SellingExpense
127494000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
307000 USD
us-gaap Interest Expense
InterestExpense
8454000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1931526000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
208192000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
48401000 USD
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
us-gaap Net Income Loss
NetIncomeLoss
159791000 USD
us-gaap Revenues
Revenues
1758140000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1411488000 USD
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
106248000 USD
us-gaap Selling Expense
SellingExpense
109150000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
118000 USD
us-gaap Interest Expense
InterestExpense
16626000 USD
us-gaap Costs And Expenses
CostsAndExpenses
1643394000 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
114746000 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
28939000 USD
us-gaap Income Loss From Subsidiaries Net Of Tax
IncomeLossFromSubsidiariesNetOfTax
0 USD
us-gaap Net Income Loss
NetIncomeLoss
85807000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202512000 USD
CY2020Q3 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
140046000 USD
CY2020Q3 us-gaap Inventory Real Estate
InventoryRealEstate
1843409000 USD
CY2020Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
25696000 USD
CY2020Q3 us-gaap Equity Method Investments
EquityMethodInvestments
34038000 USD
CY2020Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
52574000 USD
CY2020Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9205000 USD
CY2019Q4 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
125026000 USD
CY2020Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2020Q3 us-gaap Due From Affiliates
DueFromAffiliates
0 USD
CY2020Q3 us-gaap Goodwill
Goodwill
16400000 USD
CY2020Q3 us-gaap Other Assets
OtherAssets
96675000 USD
CY2020Q3 us-gaap Assets
Assets
2420555000 USD
CY2020Q3 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
176581000 USD
CY2020Q3 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
66632000 USD
CY2020Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
52666000 USD
CY2020Q3 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
0 USD
CY2020Q3 us-gaap Other Liabilities
OtherLiabilities
156390000 USD
CY2020Q3 us-gaap Special Assessment Bond Noncurrent
SpecialAssessmentBondNoncurrent
9892000 USD
CY2020Q3 mho Obligation For Consolidated Inventory Not Owned
ObligationForConsolidatedInventoryNotOwned
364000 USD
CY2020Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q3 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
136119000 USD
CY2020Q3 us-gaap Other Notes Payable
OtherNotesPayable
5325000 USD
CY2020Q3 mho Seniornotesdue2025
Seniornotesdue2025
247483000 USD
CY2020Q3 mho Seniornotesdue2028
Seniornotesdue2028
394363000 USD
CY2020Q3 us-gaap Liabilities
Liabilities
1245815000 USD
CY2020Q3 us-gaap Stockholders Equity
StockholdersEquity
1174740000 USD
CY2020Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2420555000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6083000 USD
CY2019Q4 us-gaap Loans Receivable Held For Sale Net Not Part Of Disposal Group
LoansReceivableHeldForSaleNetNotPartOfDisposalGroup
155244000 USD
CY2019Q4 us-gaap Inventory Real Estate
InventoryRealEstate
1769507000 USD
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22118000 USD
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
37885000 USD
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
18415000 USD
CY2019Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
9631000 USD
CY2019Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
0 USD
CY2019Q4 us-gaap Due From Affiliates
DueFromAffiliates
0 USD
CY2019Q4 us-gaap Goodwill
Goodwill
16400000 USD
CY2019Q4 us-gaap Other Assets
OtherAssets
70311000 USD
CY2019Q4 us-gaap Assets
Assets
2105594000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
196429000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
6083000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
202512000 USD
CY2019Q4 us-gaap Customer Advances And Deposits
CustomerAdvancesAndDeposits
34462000 USD
CY2019Q4 us-gaap Due To Affiliate Current And Noncurrent
DueToAffiliateCurrentAndNoncurrent
0 USD
CY2019Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
18415000 USD
CY2019Q4 us-gaap Other Liabilities
OtherLiabilities
147937000 USD
CY2019Q4 us-gaap Special Assessment Bond Noncurrent
SpecialAssessmentBondNoncurrent
13531000 USD
CY2019Q4 mho Obligation For Consolidated Inventory Not Owned
ObligationForConsolidatedInventoryNotOwned
7934000 USD
CY2019Q4 us-gaap Line Of Credit
LineOfCredit
66000000 USD
CY2019Q4 us-gaap Warehouse Agreement Borrowings
WarehouseAgreementBorrowings
136904000 USD
CY2019Q4 us-gaap Other Notes Payable
OtherNotesPayable
5828000 USD
CY2019Q4 mho Seniornotesdue2021
Seniornotesdue2021
298988000 USD
CY2019Q4 mho Seniornotesdue2025
Seniornotesdue2025
247092000 USD
CY2019Q4 us-gaap Liabilities
Liabilities
1102117000 USD
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
1003477000 USD
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2105594000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
197226000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8465000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
1213000 USD
mho Intercompany Investing
IntercompanyInvesting
0 USD
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
24075000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-31327000 USD
us-gaap Repayments Of Senior Debt
RepaymentsOfSeniorDebt
300000000 USD
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
400000000 USD
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
306800000 USD
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
372800000 USD
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-785000 USD
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-503000 USD
mho Intercompany Financing
IntercompanyFinancing
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
1912000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
8524000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
8254000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
30530000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
977000 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2626000 USD
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
438000 USD
mho Intercompany Investing
IntercompanyInvesting
0 USD
us-gaap Payments To Acquire Interest In Subsidiaries And Affiliates
PaymentsToAcquireInterestInSubsidiariesAndAffiliates
23522000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25710000 USD
us-gaap Proceeds From Bank Debt
ProceedsFromBankDebt
568900000 USD
us-gaap Repayments Of Bank Debt
RepaymentsOfBankDebt
496400000 USD
us-gaap Proceeds From Repayments Of Short Term Debt Maturing In Three Months Or Less
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
-44574000 USD
us-gaap Proceeds From Repayments Of Other Debt
ProceedsFromRepaymentsOfOtherDebt
-429000 USD
mho Intercompany Financing
IntercompanyFinancing
0 USD
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
5150000 USD
us-gaap Payments Of Dividends
PaymentsOfDividends
0 USD
us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
40000 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
14348000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
36655000 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
11922000 USD
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
21529000 USD
CY2019Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
33451000 USD
CY2020Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
50000000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
100000 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
1900000 USD
us-gaap Treasury Stock Shares Acquired
TreasuryStockSharesAcquired
1400000 shares
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
32800000 USD
CY2020Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
17200000 USD
CY2020Q3 us-gaap Revenues
Revenues
847921000 USD
CY2019Q3 us-gaap Revenues
Revenues
653345000 USD
us-gaap Revenues
Revenues
2139718000 USD
us-gaap Revenues
Revenues
1758140000 USD
CY2020Q3 us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
-5700000 USD
CY2019Q3 us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
-4700000 USD
us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
-16300000 USD
us-gaap Gain Loss On Oil And Gas Hedging Activity
GainLossOnOilAndGasHedgingActivity
-10700000 USD
CY2020Q3 us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
100000 USD
us-gaap Mortgage Servicing Rights Msr Impairment Recovery
MortgageServicingRightsMSRImpairmentRecovery
500000 USD

Files In Submission

Name View Source Status
0000799292-20-000114-index-headers.html Edgar Link pending
0000799292-20-000114-index.html Edgar Link pending
0000799292-20-000114.txt Edgar Link pending
0000799292-20-000114-xbrl.zip Edgar Link pending
exhibit101thirdamendme.htm Edgar Link pending
exhibit311ceocertifica.htm Edgar Link pending
exhibit312cfocertifica.htm Edgar Link pending
exhibit321ceocertifica.htm Edgar Link pending
exhibit322cfocertifica.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mho-20200930.htm Edgar Link pending
mho-20200930.xsd Edgar Link pending
mho-20200930_cal.xml Edgar Link unprocessable
mho-20200930_def.xml Edgar Link unprocessable
mho-20200930_htm.xml Edgar Link completed
mho-20200930_lab.xml Edgar Link unprocessable
mho-20200930_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending